New Key Statistics Module, Z-Score and F-Score
OTCPK:TCON Key Ratios
| Market Cap $ M | 0.28 |
| Enterprise Value $ M | -7.99 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.03 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 0.03 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3.00 |
| EPS (TTM) $ | -21.34 |
| Beneish M-Score | -14.36 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.40 |
| EV-to-EBITDA | -1.40 |
| PEG | -- |
| Shares Outstanding M | 3.41 |
| Net Margin (%) | 162.34 |
| Operating Margin % | -216.56 |
| Pre-tax Margin (%) | 162.34 |
| Quick Ratio | 0.66 |
| Current Ratio | 0.66 |
| ROA % (ttm) | 53.60 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | -396.73 |
| Dividend Yield % | -- |
| Altman Z-Score | -44.14 |
TCON Number of Guru Trades
TCON Volume of Guru Trades
Gurus Latest Trades with OTCPK:TCON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TCON is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TRACON Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:TCON
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers